In rats with heart failure, IL-10 therapy significantly improved post-MI left ventricular function by reducing IL-6 and TNF-α, whilst in ischemia-reperfusion injury, IL-10 therapy reduced inflammation and cardiomyocyte death [66,67]. This evidence concerns the gene IL6 and myocardial infarction.